𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

✍ Scribed by Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; Sei-Hoon Yang; Soo-Youl Kim; Kyeong-Man Hong

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
583 KB
Volume
136
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cytokeratin 19 fragments: A new marker f
Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer
✍ Petra Stieber; Heinz BodenmΓΌller; Dieter Banauch; Ute Hasholzner; Andreas Dessau πŸ“‚ Article πŸ“… 1993 πŸ› Elsevier Science 🌐 English βš– 360 KB

We developed a new and automated assay for the detection of lung cancer associated cytokeratin 19 fragments in patients' sera/plasma. This new tumour marker assay CYFRA 21-1 was evaluated in technical and clinical studies using the multibatch analysers ES 300 and ES 600 from Boehringer Mannheim GmbH

Apoptosis in non-small cell lung cancer
Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis
✍ G. Stammler; M. Volm πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 382 KB

The percentage of apoptotic cells among the tumor cells (apoptotic index) was determined in a series of 178 non-small cell lung carcinomas with a long term clinical follow-up by a terminal desoxynucleotidyl transferase mediated dUTP nick end labelling technique. In survival analysis, we found no sta